Eden Biosolutions PLC

Eden Biosolutions PLC

0.05
USD
+0.01
(+42.57%)
20.54MMarket Cap
Dec 16Next Earn

Total Valuation

USD

As of June 30, 2025, Eden Research plc. carries a market capitalization of 20.54M, placing it among publicly traded companies globally. Its enterprise value stands at 18.84M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap20.54M
Enterprise Value18.84M

Important Dates

Eden Research plc.'s next confirmed earnings release is scheduled for December 16, 2026.

Earnings Date12/16/2026

Share Statistics

As of June 30, 2025, Eden Research plc. has 533.35M shares outstanding.

Shares Outstanding533.35M

Valuation Ratios

These figures are as of June 30, 2025.

PB Ratio1.41
P/TBV Ratio4.61

Financial Position

As of June 30, 2025, Eden Research plc. maintains a current ratio of 2.17, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities.

Current Ratio2.17
Quick Ratio0.77
Debt / Equity5.39

Stock Price Statistics

As of the close on November 3, 2026, Eden Research plc.'s stock has gained approximately 42.57% over the past 52 weeks.

52-Week Price Change42.57%

Balance Sheet

USD

As of June 30, 2025, Eden Research plc. holds 2.53M in cash and equivalents against 785,136.47 in total debt, resulting in a net debt position of -2.53M. Total book value stands at 14.52M, with working capital of 3.87M providing operational flexibility.

Cash & Cash Equivalents2.53M
Total Debt785,136.47
Net Debt-2.53M
Equity (Book Value)14.52M
Book Value Per Share0.03
Working Capital3.87M

Stock Splits

Eden Research plc.'s most recent stock split took place on March 2, 2020.

Last Split Date3/2/2020